Related Experiment Video

Updated: Apr 4, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

88.4K

Neonatal Formulations: The Need for a Tailored, Knowledge Driven Approach

Karel Allegaert1, Katrien Cosaert, John N van den Anker

  • 1Neonatal Intensive Care Unit, University Hospital, Herestraat 49, 3000 Leuven, BELGIUM. karel.allegaert@uzleuven.be.

Current Pharmaceutical Design
|September 2, 2015
PubMed

Insights

Neonatal pharmacotherapy requires careful consideration of low and variable drug clearance. Tailored drug formulations and better understanding of excipient safety are crucial for accurate and safe dosing in newborns.

Area of Science:

  • Neonatal pharmacotherapy
  • Pediatric clinical pharmacology
  • Drug formulation development

Background:

  • Neonates exhibit low and highly variable drug clearance compared to other pediatric groups.
  • Effective and safe pharmacotherapy in neonates necessitates consideration of clinical factors and pharmacokinetics.
  • Current knowledge on excipient safety and toxicity in neonates is limited and difficult to access.

Purpose of the Study:

  • To highlight the need for tailored drug product development in neonates.
  • To emphasize the importance of addressing excipient exposure and safety.
  • To advocate for improved compounding practices for neonatal drug formulations.

Main Methods:

  • Review of existing knowledge on neonatal pharmacokinetics and excipient safety.
  • Discussion of initiatives like the Safety and Toxicity of Excipients for Pediatrics (STEP) database.
  • Highlighting feasibility studies such as the propylene glycol research project and the European Study for Neonatal Excipient Exposure (ESNEE).

Main Results:

  • Neonates require drug formulations with low and flexible dosing capabilities due to variable clearance.
  • There is a critical need for improved guidance and research on excipient safety in neonatal populations.
  • Current compounding practices require evaluation to ensure safety, stability, and accurate dosing.

Conclusions:

  • Tailored drug formulations are essential for safe and effective neonatal pharmacotherapy.
  • Further research and initiatives are needed to establish excipient safety profiles for neonates.
  • Pharmacists require support and evaluation of compounding practices to optimize neonatal drug administration.

More Related Videos

Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings04:16

Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings

Published on: February 7, 2025

1.0K
Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

835

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
482
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
750
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
377
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
804
The Nativist Approach01:21

The Nativist Approach

The nativist approach to infant cognitive development proposes that infants are born with inherent knowledge structures that allow them to interpret the world almost immediately. This perspective contrasts with earlier developmental theories, such as those proposed by Jean Piaget, which emphasized a more gradual acquisition of cognitive abilities through interaction with the environment. One key concept in this approach is object permanence — the understanding that objects continue to...
584
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K